Vernieri, Claudio <br/><br/>
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.  [electronic resource] 

 -  The oncologist  03 2019 
 - 385-393 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2018-0442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Chemotherapy, Adjuvant--methods<br/>Colonic Neoplasms--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Male<br/>Metformin--pharmacology<br/>Middle Aged<br/>Oxaliplatin--pharmacology<br/>Risk Factors